Trials / Unknown
UnknownNCT00449202
Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)
A Phase 2a Randomized, Double-Blind, Placebo Controlled, Parallel Group, Safety and Efficacy Study of Two 14 Day Cycles of Oral Doses of Oleoyl-Estrone (MP-101) in Obese Adult Subjects
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- Manhattan Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety, preliminary efficacy, and pharmacokinetics of two 14-day cycles of escalating oral doses of MP 101 in 100 obese adult subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oleoyl-estrone (MP 101) |
Timeline
- Start date
- 2006-06-01
- First posted
- 2007-03-20
- Last updated
- 2007-03-20
Locations
3 sites across 2 countries: United States, Switzerland
Source: ClinicalTrials.gov record NCT00449202. Inclusion in this directory is not an endorsement.